Dalia Megiddo

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Tel Aviv, Israel
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Dalia Megiddo
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Dalia Megiddo

Form 4 holding Chief Development Officer, Director, Founder

Nasus Pharma Ltd

Security class
Ordinary Shares
Shares / value
1,888,873
Estimated value
$17,283,943
Report date
18 Mar 2026
Price
$9.15
Ownership
Direct
Form 4 holding Chief Development Officer, Director, Founder

Nasus Pharma Ltd

Security class
Ordinary Shares
Shares / value
5,195
Estimated value
$47,536
Report date
18 Mar 2026
Price
$9.15
Ownership
By Formulex Pharma Innovations Ltd.

Insider Reports Filed by Dalia Megiddo

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .